Literature DB >> 6955008

Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.

S Fujimoto, M Ogawa, Y Sakurai.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6955008

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  2 in total

1.  Phase I study of BCNU and intravenous 6-mercaptopurine in patients with anaplastic gliomas.

Authors:  D C Smith; N A Vick; D L Trump; H S Friedman; A H Friedman; J Purvis; A Gauspari; S C Schold
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen.

Authors:  M D Prados; M S Edwards; J Rabbitt; K Lamborn; R L Davis; V A Levin
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.